Monthly Archives: May 2019

Samsung BioLogics: A World Leader in Biopharmaceutical Manufacturing

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #22 (continuation)     Samsung Biologics; A World Leader in Biopharmaceutical Manufacturing     Sponsored by Samsung BioLogics      A few days after Celltrion Press Conference by Chairman Seo Jung-jin, Samsung Biologics has issued the following report. Biopharmaceutical outsourcing for research and […]

read more

South Korea the world leading hub of biologics production?

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #22   Will South Korea become the world leading hub of biologics production?     On May 16, Celltrion Chairman Seo Jung-jin announced that the Songdo (South Korea) based company will invest 40 trillion won ($33.6 billion) and create 110,000 jobs […]

read more

Repurposing/Repositioning of Drugs

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #21   Repurposing/Repositioning of Drugs       For many years the biopharmaceutical industry has been very keen to repositioning existing active molecules for new therapeutic uses. More recently a series of small and large companies have adopted this new concept to […]

read more

LATE, a new form of dementia that mimics Alzheimer’s disease

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #20     LATE, a new form of dementia that mimics Alzheimer’s disease     In the latest issue of Brain, an international team of scientists and clinicians led by Peter Nelson at the University of Kentucky in Lexington, describe a […]

read more